Market Tracker

12/19 3:24am ET

Gilead Sciences Inc (NASDAQ:GILD)

105.54
Data as of Dec 18
 +3.14 / +3.07%
Today’s Change
63.50
Today|||52-Week Range
116.83
+40.53%
Year-to-Date

Today’s Trading

Previous close102.40
Today’s open104.48
Day’s range-- - --
Volume14,285,619
Average volume (3 months)15,020,821
Market cap$154.5B
Dividend yield--
Data as of 12/18/2014

Growth & Valuation

Earnings growth (last year)+10.37%
Earnings growth (this year)+288.48%
Earnings growth (next 5 years)+25.64%
Revenue growth (last year)+16.72%
P/E ratio18.7
Price/Sales10.23
Price/Book13.82

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+5.00+3.06%
BIIBBiogen+20.81+6.25%
BAXBaxter International...+1.80+2.49%
GEVASynageva BioPharma C...-1.04-1.08%
Data as of 4:00pm ET, 12/18/2014

Financials

Next reporting dateJanuary 27, 2015
EPS forecast (this quarter)$2.27
Annual revenue (last year)$11.2B
Annual profit (last year)$3.1B
Net profit margin27.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts